Membrane Chromatography Market

The membrane chromatography market is projected to reach USD 0.63 billion by 2031 from an estimated USD 0.37 billion in 2026, at a CAGR of 11.3% during the forecast period. Market growth is driven by the advantages offered by membrane chromatography over conventional resin-based chromatography, increasing biopharmaceutical R&D, rising production of biologics, and growing adoption of single-use downstream processing technologies. Increasing manufacturing of monoclonal antibodies, recombinant proteins, vaccines, viral vectors, plasmid DNA, mRNA, and other advanced therapeutic modalities is driving demand for rapid, scalable purification technologies. The growing use of flow-through processing, affinity capture, ion exchange purification, and high-throughput polishing further supports market expansion. Demand for capsules, cassettes & cartridges, membrane discs & sheets, syringe filters, filter plates, spin columns, and other consumables is also increasing across process development and commercial biomanufacturing.

The global membrane chromatography market is consolidated, with Danaher Corporation (US), Sartorius AG (Germany), Merck KGaA (Germany), and Thermo Fisher Scientific Inc. (US) being the major participants. Competition centers on membrane binding capacity, throughput, scalability, chemistry portfolio, application coverage, single-use compatibility, and the ability to support customers from process development through commercial manufacturing. Product innovation, portfolio expansion, and strategic acquisitions, collaborations, and partnerships are prominent strategies market participants use. Sartorius and Merck have expanded their membrane chromatography portfolios through new affinity and ion exchange membrane products, while Thermo Fisher Scientific and Danaher have strengthened their downstream processing capabilities through portfolio integration and acquisitions.

To know about the assumptions considered for the study download the pdf brochure

In September 2025, Merck KGaA launched the Natrix CH chromatography membrane device family, expanding its membrane chromatography portfolio with a scalable cation exchange solution for purification of traditional and novel therapeutic modalities.

In September 2025, Thermo Fisher Scientific completed the acquisition of Solventum’s Purification & Filtration business for approximately USD 4.0 billion, strengthening its bioprocessing portfolio with additional filtration and membrane technologies serving upstream and downstream workflows.

Danaher Corporation (US)

Danaher Corporation is a leading player in the membrane chromatography market through Cytiva. Its portfolio includes Mustang membrane chromatography products, such as Mustang Q membrane adsorbers and related capsule and multiwell formats used for capture and impurity removal from laboratory screening through manufacturing scale. The company’s core competency lies in integrating chromatography, filtration, single-use technologies, and downstream bioprocessing solutions. Mustang products use high-throughput membrane formats designed to reduce processing time and support flexible scale-up. In May 2023, Pall Life Sciences was integrated with Cytiva, combining complementary filtration, separation, and bioprocessing capabilities under the Cytiva business and strengthening Danaher’s end-to-end downstream processing offering.

Sartorius AG (Germany)

Sartorius AG has a strong position in membrane chromatography through its Sartobind portfolio. The company offers affinity, anion exchange, cation exchange, and hydrophobic interaction membrane chromatography solutions for monoclonal antibody purification, viral vector processing, nucleic acid purification, capture, and polishing applications. Its core competencies include scalable single-use membrane formats, rapid-cycling chromatography, and process transfer from lab development to commercial manufacturing. In October 2024, Sartorius launched Sartobind Rapid A Lab, a Protein A affinity membrane solution designed to accelerate antibody capture and provide a scalable pathway toward process-scale manufacturing. Sartorius also focuses on partnerships to strengthen integrated downstream workflows, including its collaboration with Waters for process-scale chromatography and analytical technologies.

Merck KGaA (Germany)

Merck KGaA participates in the membrane chromatography market through its broader Life Science downstream processing portfolio. The company’s membrane chromatography capabilities include the Natrix Q and Natrix CH platforms, supporting high-throughput ion exchange purification and scalable processing of biologics and emerging therapeutic modalities. Its core competencies include chromatography, filtration, single-use processing, and integrated downstream purification technologies. The launch of the Natrix CH chromatography membrane device family in 2025 expanded Merck’s cation exchange membrane chromatography capabilities and strengthened its offering for intensified purification workflows. The company’s combination of membrane chromatography with filtration and other bioprocessing technologies supports broader integration across downstream manufacturing operations.

Thermo Fisher Scientific Inc. (US)

Thermo Fisher Scientific offers membrane-based purification solutions as part of its broader bioproduction portfolio. Its membrane chromatography offering includes the GoPure AAVX Affinity Membrane, introduced in September 2025 for rapid capture of adeno-associated viral vectors using CaptureSelect AAVX ligand technology. The company’s core competencies span bioprocessing, filtration, chromatography, single-use technologies, and advanced therapy manufacturing. Thermo Fisher further strengthened these capabilities through its 2025 acquisition of Solventum’s Purification & Filtration business, adding membrane and filtration technologies across upstream and downstream bioprocessing workflows. This portfolio expansion strengthens the company’s ability to provide integrated solutions to pharmaceutical and biotechnology manufacturers.

Market Ranking

The membrane chromatography market is consolidated, with Danaher Corporation (US), Sartorius AG (Germany), Merck KGaA (Germany), and Thermo Fisher Scientific Inc. (US) collectively accounting for approximately 73–77% of the global market in 2025. Danaher Corporation maintains a strong position through Cytiva’s Mustang membrane chromatography portfolio, offering membrane adsorbers for capture, polishing, and impurity-removal applications across development and manufacturing scales. Sartorius AG has a broad presence through its Sartobind portfolio, spanning affinity, anion exchange, cation exchange, and hydrophobic interaction membrane chromatography solutions. Merck KGaA strengthens its position through the Natrix platform and its broader chromatography, filtration, and single-use downstream processing portfolio. Thermo Fisher Scientific Inc. participates through membrane-based purification solutions, including GoPure affinity membranes, supported by its broader filtration and separation capabilities.

The remaining share of the market, approximately 23–27%, is held by key companies such as i3 Membrane GmbH (Germany), Agilent Technologies, Inc. (US), Donaldson Company, Inc. (US), GVS S.p.A. (Italy), Restek Corporation (US), Shimadzu Corporation (Japan), W. L. Gore & Associates, Inc. (US), MACHEREY-NAGEL GmbH & Co. KG (Germany), and MICROSOLV (US), among others. Competition is driven by membrane binding capacity, selectivity, throughput, scalability, chemistry portfolio, single-use compatibility, and technical support. These companies compete through specialized membrane formats, application-specific purification solutions, portfolio expansion, product innovation, and broader participation across biopharmaceutical research and downstream processing workflows.

Related Reports:

Membrane Chromatography Market by Product (Capsules, Cassettes, Cartridges, Syringe Filters, Spin Column), Technique (Ion Exchange, Affinity), Operation Mode (Flow Through, Bind Elute), Material (PES, Cellulose), End User, Region - Global Forecast to 2031

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
[email protected]